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Abstract: This paper reports for the first time the effect of an acetone extract of 
Umbilicaria crustulosa on the micronucleus distribution of human lympho-
cytes, and on the cholinesterase activity and antioxidant activity by the cupric 
ion reducing antioxidant capacity (CUPRAC) method. Additionally, the total 
phenolic compounds (TPC) and the antioxidant properties were estimated via 
DPPH, ABTS and TRP assays. Moreover, the antibacterial activity against two 
Gram-positive and three Gram-negative bacteria were determined. Acetone 
extract of U. crustulosa at concentration of 1 and 2 µg mL-1 decreased a fre-
quency of micronuclei (MN) by 10.8 and 16.8 %, respectively, acting more or 
slightly less than the synthetic protector amifostine (AMF, WR-2721, 11.4 %, 
at concentration of 1 µg mL-1). The tested extract did not inhibit cholinesterase 
activity nor did it exhibit activity toward the examined bacteria. The extract 
reduced the concentration of DPPH and ABTS radicals by 88.7 and 96.2 %, 
respectively. Values for total reducing power (TRP) and cupric reducing cap-
acity (CUPRAC) were 0.6197±0.0166 µg ascorbic acid equivalents (AAE) per 
mg of dry extract, and 19.7641±1.6546 µg trolox equivalents (TE) per mg of 
dry extract, respectively. The total phenol content was 350.4188 ±14.587 µg 
gallic acid equivalents (GAE) per mg of dry extract. The results of the present 
study showed that U. crustulosa acetone extract is a promising candidate for in 
vivo experiments considering its antioxidant activity and protective effect on 
human lymphocytes. 
Keywords: micronucleus test; antioxidant activity; cholinesterase inhibition; 
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INTRODUCTION 
Lichens of the genus Umbilicaria are generally known as rock tripe. These 
species grow on siliceous rocks usually in the Alpine vegetation zone and the 
Northern hemisphere.1 Some of these species are used as food and represent a 
part of folk medicine.2,3 Umbilicaria crustulosa (Ach.) Frey is known as a crusty 
novel lichen. Serina and Arroyo found two U. crustulosa chemotypes in samples 
growing in Spain: gyrophoric acid and crustinic acid chemotype. Beside crustinic 
and gyrophoric acids, Umbilicaria species are characterized by the presence of 
lecanoric, hiascic, ovoic, umbilicaric, salazinic and norstictic acids.3,4  
The presence of phenolic groups in the structure of the constituents of U. 
crustulosa extracts results in their antioxidant activity.3,5 Antioxidants could pre-
vent oxidation of biomolecules in food as well as in human cells. Industrial anti-
oxidants are mostly synthetic components which could have negative impacts on 
human health.6 Natural antioxidants are very important source of protection 
against free radicals, which could be related to many disease such as Alzheimer's 
disease, atherosclerosis, emphysema and many forms of cancer.7,8 A decrease in 
the amount of acetylcholine in the brain is the hallmark of Alzheimer's disease. 
Some synthetic cholinesterase inhibitors are used for the treatment of disease but 
an alternative approach could be the utilization of natural anticholinesterases.9 
According to published data, Hypogimnia physodes extracts and lichens second-
ary metabolites have an impact on micronucleus (MN) expression in peripheral 
blood lymphocytes.10,11 Micronuclei result from lesions/adducts at the level of 
DNA or chromosomes, or at the level of proteins directly or indirectly involved 
in chromosome segregation. The cytokinesis-block micronucleus technique 
enables micronuclei to be specifically scored in cells that have completed nuclear 
division and is, therefore, not influenced by variations in cell division kinetics, and 
it has been shown to be a sensitive and reliable index of chromosome damage.12 
Taking into account the above-mentioned biological activities of the lichens, 
the aim of present study was to evaluate for the first time effect of U. crustulosa 
acetone extract on the micronucleus distribution in human lymphocytes, and the 
effect on cholinesterase and antioxidant activity by the CUPRAC method.  
Additionally, total phenolic compounds (TPC), the antioxidant properties 
estimated via 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging radical capacity, 
2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scav-
enging activity and TRP (total reduction power) assays as well as the antibac-
terial activity against two Gram-positive (Bacillus subtilis subsp. spizizenii 
ATCC 6633 and Staphylococcus aureus ATCC 6538) and three Gram-negative 
bacteria (Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027 
and Salmonella abony NCTC 6017) were determined.  
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EXPERIMENTAL 
Lichen material 
The lichen Umbilicaria crustulosa (Ach.) Frey (syn. Gyrophora depressa (Ach.) Schaer, 
Omphalodiscus crustulosus (Ach.) Schol, Gyrophora crustulosa (Ach.), Gyrophora spod-
ochroa var. crustulosa (Ach.) Arnold, Gyrophoropsis crustulosa (Ach.) Räsänen) was col-
lected in May 2015, from the peak of Mount Babin zub (1650 m above sea level, coordinates 
43° 23′ N, 22° 40′ E; Stara planina Mountain, Serbia) from the population growing on rock 
habitat (red sandstone, silicates). A voucher specimen has been deposited in the Herbarium 
collection at the Department of Biology and Ecology, Faculty of Science and Mathematics, 
University of Niš under the acquisition number 9373. The lichen material was air-dried 
without exposure to direct sunlight for 10 days and stored at ambient temperature (25±2 °C) 
prior to further treatment.  
Extraction  
Extracts were prepared in triplicate according to the following procedure: powdered 
lichen material (10 g) was first subjected to ultrasound-assisted extraction with acetone (50 
mL; 30 min in an ultrasound bath, type UZK 8; manufactured by Maget, Bela Palanka, Serbia. 
Subsequently, the extract was left in the dark (at room temperature) for an additional five 
days. Dry residues of the extracts were obtained using a rotary evaporator with the water bath 
set at 40 °C. The extract yield was 7.4±0.5 %.  
HPLC analysis 
HPLC analysis was performed on an Agilent, Zorbax Eclipse XDB-C18, 5 μm, 4.6 
mm×150 mm column using an Agilent 1200 series liquid chromatograph (equipped with a 
diode array detector (DAD), Chemstation Software (Agilent Technologies), a quaternary pump, 
an online vacuum degasser, auto sampler and a thermostated column compartment. The mob-
ile phase, methanol–water–formic acid (80:20:0.2 volume ratios), was pumped at a flow rate 
of 0.5 mL min-1, the injection volume was 5 μL (concentration 10 mg of the dry extract per 1 mL 
of acetone), at 25 °C. The spectra were acquired in the range 190–400 nm and the chroma-
togram plotted at 254 nm. Identification was conducted using retention times and UV spectra. 
Cytokinesis-block micronucleus assay (CBMN) 
The cytokinesis-block micronucleus assay was performed as previously described.10,12 
Cell culture lymphocytes were treated with 1.0, 2.0 and 3.0 μg mL-1 of the examined extracts. 
Amifostine, WR-2721 (98 % S-[2-[(3-aminopropyl)amino]ethyl]phosphothioate; Marligen 
Biosciences) at a concentration of 1 μg mL-1 was used as a positive control. Three experi-
ments were performed for each sample. The results are expressed as the means ± standard 
deviation (SD). 
The statistical analysis was performed using Origin software package version 7.0. The 
statistical significance of difference between the data pairs was evaluated by analysis of 
variance (one-way ANOVA) followed by the Tukey test. Statistical difference was considered 
significant at p < 0.01 and p < 0.05. 
Total phenolic content and antioxidant activity  
Determination of the total phenolic content (TPC) and four antioxidant assays, i.e., 
DPPH and ABTS scavenging radical capacity, CUPRAC (cupric reducing antioxidant cap-
acity) and TRP (total reducing power), were performed as previously described.13,14 All spec-
trophotometric assays were conducted on a Perkin Elmer lambda 15 double beam UV/Vis 
spectrophotometer. For all the above-mentioned experiments, the concentration of the sample 
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solution was 15 mg of extract per mL of methanol. All analyses were performed in triplicate. 
The results are presented as mean ± standard deviation (SD). 
Cholinesterase activity 
Assessment of the effect of the extract on cholinesterase activity was performed as 
previously described.15 The activity was measured spectrophotometrically using a Konelab 20 
analyzer (Thermo Fisher Scientific, Helsinki, Finland) with thermostated flow cells, length 7 
mm (at a wavelength 405 nm). The sample concentration was 10 mg of dry extract per 1 mL 
of DMSO. A solution of neostigmine bromide at a concentration of 200 µg mL-1 was used as 
the reference standard.  
Antimicrobial activity 
Antimicrobial activity was evaluated against two Gram-positive (Bacillus subtilis subsp. 
spizizenii ATCC 6633 and Staphylococcus aureus ATCC 6538) and three Gram-negative 
(Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027 and Salmonella abony 
NCTC 6017) bacteria. Analysis was performed according to the National Committee for Clin-
ical Laboratory Standards (NCCLS).16 Each test was performed in triplicate. The sample 
concentration was 1 mg per disk (diameter 12 mm). Streptomycin and chloramphenicol were 
used as positive controls, at a concentration of 10 mg and 30 mg per disk, respectively. 
RESULTS AND DISCUSSION 
HPLC analysis 
The HPLC chromatogram of the acetone extract of U. crustulosa and the UV 
spectra of the identified constituents are presented in Fig. 1. 
Chemical composition and structures of the constituents are given in Table I. 
The most abundant component of the acetone extract of U. crustulosa is the tri-
depside gyrophoric acid and this sample could be classified as a gyrophoric acid 
chemotype.4 
The major components of the extract were the didepside lecanoric acid and 
the tridepside gyrophoric acid, comprised of two and three, respectively, orsel-
linic acid units joined with ester bonds at the para-positions. Crustinic acid is an 
exception, as it has the ester bonded at the meta-position of the third ring. No 
direct evidence is available on the biosynthesis of meta-depsides. The co-occur-
rence and interconversion of the depsides meta- and para-scrobiculin, which 
exist in dynamic equilibrium, in Lobaria scrobiculata led to the hypothesis that 
meta-depsides are formed from para-depsides via an intramolecular rearrange-
ment after hydroxylation of the carbon at the meta-position of the B-ring.17 
Cytokinesis-block micronucleus assay (CBMN) 
The extract was tested for in vitro protective effect on chromosome aber-
rations in peripheral human lymphocytes using the cytochalasin-B blocked MN 
assay at concentrations of 1.0, 2.0 and 3.0 μg mL–1. The frequencies and distri-
bution of MN in human lymphocytes were scored. The statistical significance of 
difference between the data pairs was evaluated by analysis of variance (One-
way ANOVA) followed by the Tukey test. The results are presented in Table II. 
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TABLE I. Composition (as percentages of the total peak area of the HPLC chromatograms 
recorded at 254 nm) and structures of the constituents of the U. crustulosa extract 
Component 
number Cmpd. Structure 
Rt / 
min 
HPLC peak 
area, % 
1 Methyl 
orsellinate COOCH3
CH3
OHHO
1
2
3
4
5
6 7
8
H
H
4.262 2.1 
2 Lecanoric 
acid 
COOHO
OH
CH3
OH
COOH
CH3
1
23
4
5 6
7 1'
2'3'
4'
5' 6'
7'
8'
4.720 23.5 
3 Crustinic 
acid 
COOHO
OH
CH3
OH
COO
CH3
1
23
4
5 6
7
8
1'
2'3'
4'
5' 6'
7'
8'
H3C COOH
OH
HO
1"
2"
3"4"
5"
6"
7"8"
5.582 0.1 
4 Gyrophoric 
acid 
COOHO
OH
CH3
OH
COO
CH3
OH
COOH
CH3
1
23
4
5 6
7 1'
2'3'
4'
5' 6'
7' 1''
2''3''
4''
5'' 6''
7''
7.384 68.6 
TABLE II. Incidence of MN, cytokinesis-block proliferation index, distribution of MN per 
cells (mean ± SD) and frequency of MN in cell cultures of human lymphocytes treated with 
different concentration of Umbilicaria crustulosa acetone extract (AE); MN/1000 Bn cells – 
incidence of micronuclei in 1000 binucleated cells; % Bn cells with micronuclei; MN/Bn cells – 
incidence of micronuclei in binucleated cells; CBPI – cytokinesis-block proliferation index; Fre-
quency of MN – incidence of MN present as % from control groups in cell cultures of human 
lymphocytes treated with different concentration of extracts; a* – statistically significant difference 
from control at p < 0.05 
Concentrations MN/1000 Bn cells 
Bn cells 
with MN, %
MN/Bn 
Cells CBPI 
Frequency of MN 
rel. to control, % 
Untreated cells 25.83±0.58 2.06±0.12 1.25±0.06 1.63±0.03 100.00 
Amifostin 
(1 µg mL-1) 
22.89±0.68a* 1.87±0.06 1.22±0.06 1.62±0.04 88.62 
AE (1 µg mL-1) 23.05±1.06 1.89±0.08 1.22±0.06 1.68±0.06 89.24 
AE (2 µg mL-1) 21.60±1.68 1.62±0.13 1.34±0.13 1.63±0.01 83.62 
AE (3 µg mL-1) 24.24±1.21 2.06±0.12 1.18±0.04 1.63±0.02 93.84 
The cell cultures treated with amifostine (radioprotectant, previously known 
as WR-2721) at a concentration of 1 μg mL–1 resulted in a decrease of the MN 
frequency of 11.4 % compared to the control cell cultures (statistically signific-
ant, p < 0.05). The U. crustulosa extract at a concentration of 2 μg mL–1 gave a 
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decrease in the MN frequency of 16.38 %, which was higher than that with ami-
fostine, while at a concentration of 1 μg mL–1, the effect was 10.8 %, which is 
slightly less than the effect of amifostine. The U. crustulosa extract at a concen-
tration of 3 µg mL–1 was less effective (6.2 %) than amifostine. 
Since the number of micronuclei serves as an indicator of DNA damage, 
these results indicate that the examined extract at a concentration of 2 μg mL–1 
protects DNA. Previous results of H. physodes extracts suggested a similar con-
clusion. A diethyl ether extract of the lichen H. physodes at a concentration of 
1 μg mL–1 caused a significant decrease in the frequency of micronuclei, 17.4 %, 
while it was less effective at a concentration of 2 μg mL–1.11 
The effect of examined extracts on cell proliferation was investigated by 
determining the cytokinesis-block proliferation index (CBPI), calculated as 
[(MI + 2MII + 3(MIII + MIV)]/N, where MI–IV represent the number of cells with 
1 to 4 nuclei, respectively, and N is the number of cells scored.18 The comparable 
CBPI values of extracts, amifostine WR-2721 and untreated cells have confirmed 
absence of the impact on the cell proliferation. This fact is important for validity 
of the results because MN expression is dependent on cell division.  
The total phenolic content and antioxidant activity 
TPC analysis showed a high content of phenolic components in the acetone 
extract of U. crustulosa, 350.4188±14.587 µg GAE mg–1 due to the presence of 
the tridepside gyrophoric acid and the didepside lecanoric acid (total 92.0 % of 
the sample). It was not possible to compare the present results expressed as galic 
acid equivalents (GAE) with those of Kosanic et al. because they expressed the 
amount of total phenolic compounds as the pyrocatechol equivalent.19 
The assessment of the DPPH and ABTS scavenging activity showed that 
extract reduced the concentration of DPPH and ABTS radicals by 88.7 and 96.2 
%, respectively, which is consistent with previously published results. Namely, 
Kosanic et al. found that the scavenging activity of a methanol extract of U. crus-
tulosa was 79.85 %, while Buçukoglu et al. found that the values of the DPPH 
scavenging activity of gyrophoric and leconaric acids were 50.96 and 32.48 %, 
respectively.19,20 
The value of the total reducing power ability (TRP, ability of antioxidants to 
reduce hexacyanidoferrate (III) to hexacyanidoferrate (II), which leads to an inc-
rease in the absorbance of the reaction mixtures) was 0.6197±0.0166 mg ascorbic 
acid equivalents (AAE) per mg dry extract weight. Again, it was not possible to 
compare the obtained results with those previously published due to the different 
expression of the results (absorbance vs. AAE).19 
The CUPRAC assay has some advantages compared to the other experi-
ments since the reagent is stable, accessible, low-cost, and the reaction (reduction 
of a cupric neocuproine complex (Cu(II)–Nc) by antioxidants to the cuprous 
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form (Cu(I)–Nc)) is realized at nearly physiological pH. The result obtained for 
the U. crustulosa acetone extracts (19.7641±0.0166 mg trolox equivalents (TE) 
per mg dry extract) is close to the highest CUPRAC capacity of mushrooms 
(21.738–4.164 mg TE per mg dw).13 
Cholinesterase activity  
Results obtained from the screening of the interaction of the extract with 
cholinesterase from pooled human serum showed that U. crustulosa possess a 
weak activation effect on the cholinesterase activity. In the conducted experi-
ment, neostigmin bromide (commercial cholinesterase inhibitor) inhibited cholin-
esterase to extent of 96.6 % while U. crustulosa extract manifested weak activat-
ion effect on cholinesterase to an extent of 1.6 %. 
Antibacterial activity 
The results of the antibacterial assays against two Gram-positive (B. subtilis 
subsp. spizizenii ATCC 6633 and S. aureus ATCC 6538) and three Gram- 
-negative bacteria (E. coli ATCC 8739, P. aeruginosa ATCC 9027 and S. abony 
NCTC 6017) showed that the acetone extract of U. crustulosa had no activity 
against the tested bacteria at a concentration of 1 mg per disk. These results were 
not entirely in accordance with those previously published. Namely, Rankovic et 
al. and Kosanic et al. reported no activity toward Escherichia coli, Botrytis 
cinerea and Candida albicans but moderate antimicrobial activity of methanol 
and acetone extracts of U. crustulosa to several bacteria and fungi, such as: Bac-
illus mycoides, Bacillus subtilis, Enterobacter cloaceae, Klebsiella pneumoniae, 
Staphylococcus aureus, Aspergillus flavus, Aspergillus fumigatus, Fusarium oxy-
sporum, Mucor mucedo, Paecilomyces variotii , Penicillium purpurescens, Peni-
cillium verrucosum, Saccharomyces cerevisiae, Trichoderma harzianum.2,19 
Bucukoglu et al. and Candan et al. found that gyrophoric acid was not effective 
against B. subtilis, E. coli, K. pneumoniae, P. aeruginosa and Salmonela typhi-
murium.20,21 Since gyrophoric acid participated 68.5 % to the extract compo-
sition, the results obtained in the present study could be explained by its inactivity. 
CONCLUSION 
The results of present study show that U. crustulosa acetone extract is a 
promising candidate for in vivo experiments considering antioxidant activity and 
protective effect on human lymphocytes, which could not be said for its anti-
bacterial and anti-cholinesterase activity.  
Acknowledgement. The authors acknowledge the Ministry of Education, Science and 
Technological Development of the Republic of Serbia for the financial support (Grant No. 
172047). 
_________________________________________________________________________________________________________________________
(CC) 2017 SCS.
Available on line at www.shd.org.rs/JSCS/
 BIOLOGICAL ACTIVITIES OF U. crustulosa 149 
И З В О Д  
БИОЛОШКА АКТИВНОСТ АЦЕТОНСКОГ ЕКСТРАКТА ЛИШАЈА 
Umbilicaria crustulosa (ACH.) FREY  
ИВАНА ЗЛАТАНОВИЋ1, МИРОСЛАВА СТАНКОВИЋ2, ВЕСНА СТАНКОВ ЈОВАНОВИЋ1, ВИОЛЕТА МИТИЋ1, 
ИВАНА ЗРНЗЕВИЋ1, АЛЕКСАНДРА ЂОРЂЕВИЂ1 и ГОРДАНА СТОЈАНОВИЋ1 
1Департман за хемију, Природно–математички факултет, Универзитет у Нишу, Вишеградска 33, 
18 000 Ниш и 2Институт за нуклеарне науке Винча, Мике Петровића Аласа 12–14, 11351 Винча 
У овом раду је по први пут испитан утицај ацетонског екстракта лишаја Umbilicaria 
crustulosa (Ach.) Frey на дистрибуцију микронуклеуса у људским лимфоцитима, холи-
нестеразну активност и антиоксидативну активност коришћењем CUPRAC методе. Укуп-
ни садржај фенола, антиоксидативна својства (процењена коришћењем DPPH, ABTS и 
TRP тестова), као и антибактеријска активност према две грам-позитивне и три грам- 
-негативне бактерије су такође одређени. Ацетонски екстракт лишаја U. crustulosa у кон-
центрацији од 1 и 2 μg mL-1 смањује фреквенцију микронуклеуса (МН) за 10,8 и 11,4 %, 
редом, делујући јаче или нешто слабије од комерцијалног заштитног агенса амифостина 
(AMF, WR-2721), 11,4 % у концентрацији 1 μg mL-1). Испитивани екстракт није показао 
инхибицију активности холинестеразе, као ни активност према тестираним бактеријама. 
Екстракт смањује концентрацију DPPH и ABTS радикала за 88,7 и 96,2 %, редом. Вред-
ности укупне редукционе моћи (TRP) и купрак-редукционог капацитета (CUPRAC) су 
0,6197±0,0166 mg еквивалента аскорбинске киселине (AAE) по mg сувог екстракта и 
19,7641±1,6546 mg тролокс еквивалента (TE) по mg сувог екстракта, редом. Укупни 
садржај фенола је 350,4188±14,587 mg еквивалената галне киселине по mg сувог екс-
тракта. Резултати испитивања су показали да је U. crustulosa обећавајући кандидат за in 
vivo испитивања у погледу антиоксидативне активности и заштитног ефекта на људске 
лимфоците. 
(Примљено 19. октобра, ревидирано 16. децембра, прихваћено 21. децембра 2016) 
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